Skip to main content
SpringerLink
Log in

Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

To investigate whether grade II oligodendroglioma was transformed to glioblastoma or not, histopathological evaluation of recurrent oligodendrogliomal tumors (OG) and diffuse astrocytomas (DA) was performed. The OG group was composed of ten patients with OG, including seven oligodendrogliomas and three oligoastrocytomas. The DA group was composed of ten patients with DA, including eight fibrillary astrocytomas and two gemistocytic astrocytomas. The histopathological parameters of glioblastoma including nuclear atypia, multinucleated giant cells, glomeruloid tufts (GT) as a marker of microvascular proliferation, necrosis, and the Ki-67 staining index were investigated. Evaluation of these parameters was scored as follows: 0, none; 1, sporadic; 2, partial; 3, extensive. There were no cases of transformation to glioblastoma in the OG group. There were five cases of transformation to secondary glioblastoma in the DA group. In recurrent tumors, scores of GT and necrosis in the OG group were significantly lower than those in the DA group (p < 0.005). Nuclear atypia and high proliferative activity (Ki-67 index) were identified in recurrent tumors of the OG group. Our study suggested that the extent of GT and necrosis in recurrent OG was less than that in recurrent DA, and transformation to glioblastoma from oligodendroglial tumor was exceptional.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Scherer HJ (1940) Cerebral astrocytomas and their derivatives. Am J Cancer 40:159–198

    Google Scholar 

  2. Reifenberger G, Kros JM, Louis DN, Collins VP (2007) Oliogodendroglioma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC press, Lyon, pp 54–65

    Google Scholar 

  3. Ohgaki H, Watanabe K, Peraud A, Biernat W, von Deimling A, Yasargil MG, Yonekawa Y, Kleihues P (1999) A case history of glioma progression. Acta Neuropathol 97(5):525–532

    Article  PubMed  CAS  Google Scholar 

  4. Kleihues P, Louis DN, Wiestler OD, Burger PC, Scheithauer BW (2007) WHO grading of tumours of the central nervous system. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC press, Lyon, pp 54–65

    Google Scholar 

  5. Mørk SJ, Halvorsen TB, Lindegaard KF, Eide GE (1986) Oligodendroglioma. Histologic evaluation and prognosis. J Neuropathol Exp Neurol 45:65–78

    Article  PubMed  Google Scholar 

  6. Burger PC, Rawlings CE, Cox EB, McLendon RE, Schold SC Jr, Bullard DE (1987) Clinicopathologic correlations in the oligodendroglioma. Cancer 59:1345–1352

    Article  PubMed  CAS  Google Scholar 

  7. Daumas-Duport C, Tucker ML, Kolles H, Cervera P, Beuvon F, Varlet P, Udo N, Koziak M, Chodkiewicz JP (1997) Oligodendrogliomas. Part II: a new grading system based on morphological and imaging criteria. J Neurooncol 34:61–78

    Article  PubMed  CAS  Google Scholar 

  8. Giannini C, Scheithauer BW, Weaver AL, Burger PC, Kros JM, Mork S, Graeber MB, Bauserman S, Buckner JC, Burton J, Riepe R, Tazelaar HD, Nascimento AG, Crotty T, Keeney GL, Pernicone P, Altermatt H (2001) Oligodendrogliomas: reproducibility and prognostic value of histologic diagnosis and grading. J Neuropathol Exp Neurol 60:248–262

    PubMed  CAS  Google Scholar 

  9. Miller CR, Dunham CP, Scheithauer BW, Perry A (2006) Significance of necrosis in grading of oligodendroglial neoplasms: a clinicopathologic and genetic study of newly diagnosed high-grade gliomas. J Clin Oncol 24:5419–5426

    Article  PubMed  Google Scholar 

  10. Jenkins RB, Blair H, Ballman KV, Giannini C, Arusell RM, Law M et al (2006) A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma. Cancer Res 66:9852–9861

    Article  PubMed  CAS  Google Scholar 

  11. Cairncross JG, Ueki K, Zlatescu MC, Lisle DK, Finkelstein DM, Hammond RR et al (1998) Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. J Natl Cancer Inst 90:1473–1479

    Article  PubMed  CAS  Google Scholar 

  12. Bauman GS, Ino Y, Ueki K, Zlatescu MC, Fisher BJ, Macdonald DR et al (2000) Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. Int J Radiat Oncol Biol Phys 48:825–830

    Article  PubMed  CAS  Google Scholar 

  13. Fallon KB, Palmer CA, Roth KA, Nabors LB, Wang W, Carpenter M et al (2004) Prognostic value of 1p, 19q, 9p, 10q, and EGFR-FISH analyses in recurrent oligodendrogliomas. J Neuropathol Exp Neurol 63:314–322

    PubMed  CAS  Google Scholar 

  14. Felsberg J, Erkwoh A, Sabel MC, Kirsch L, Fimmers R, Blaschke B et al (2004) Oligodendroglial tumors: refinement of candidate regions on chromosome arm 1p and correlation of 1p/19q status with survival. Brain Pathol 14:121–130

    Article  PubMed  CAS  Google Scholar 

  15. Eoli M, Bissola L, Bruzzone MG, Pollo B, Maccagnano C, De Simone T et al (2006) Reclassification of oligoastrocytomas by loss of heterozygosity studies. Int J Cancer 119:84–90

    Article  PubMed  CAS  Google Scholar 

  16. Kouwenhoven MC, Kros JM, French PJ, Biemond-ter Stege EM, Graveland WJ, Taphoorn MJ et al (2006) 1p/19q loss within oligodendroglioma is predictive for response to first line temozolomide but not to salvage treatment. Eur J Cancer 42:2499–2503

    Article  PubMed  CAS  Google Scholar 

  17. van den Bent MJ, Carpentier AF, Brandes AA, Sanson M, Taphoorn MJ, Bernsen HJ et al (2006) Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial. J Clin Oncol 24:2715–2722

    Article  PubMed  Google Scholar 

  18. Campbell BA, Horsman DE, Maguire J, Young S, Curman D, Ma R, Thiessen B (2008) Chromosomal alterations in oligodendroglial tumours over multiple surgeries: is tumour progression associated with change in 1p/19q status? J Neurooncol 89:37–45

    Article  PubMed  CAS  Google Scholar 

  19. Jeuken JW, Sprenger SH, Vermeer H, Kappelle AC, Boerman RH, Wesseling P (2002) Chromosomal imbalances in primary oligodendroglial tumors and their recurrences: clues about malignant progression detected using comparative genomic hybridization. J Neurosurg 96:559–564

    Article  PubMed  Google Scholar 

  20. Brandes AA, Tosoni A, Cavallo G, Reni M, Franceschi E, Bonaldi L, Bertorelle R, Gardiman M, Ghimenton C, Iuzzolino P, Pession A, Blatt V, Ermani M (2006) Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study. J Clin Oncol 24:4746–4753

    Article  PubMed  CAS  Google Scholar 

  21. Donahue B, Scott CB, Nelson JS et al (1997) Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02. Int J Radiat Oncol Biol Phys 38:911–914

    Article  PubMed  CAS  Google Scholar 

  22. Dehais C, Laigle-Donadey F, Marie Y et al (2006) Prognostic stratification of patients ith anaplastic gliomas according to genetic profile. Cancer 107:1891–1897

    Article  PubMed  CAS  Google Scholar 

  23. Smith JS, Perry A, Borell TJ et al (2000) Alterations of chromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoastrocytomas. J Clin Oncol 18:636–645

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Faculty of Medical Sciences, University of Fukui, 23-3 Matsuoka-Shimoaizuki, Eiheiji, Fukui, 910-1193, Japan

    Hiroaki Takeuchi, Tetsuya Hosoda, Ryuhei Kitai, Toshiaki Kodera, Hidetaka Arishima, Kenzo Tsunetoshi, Hiroyuki Neishi, Takahiro Yamauchi, Kazufumi Sato & Ken-ichiro Kikuta

  2. Department of Pathology, Faculty of Medical Sciences, University of Fukui, Fukui, Japan

    Yoshiyuki Imamura & Hiroshi Itoh

  3. Department of Neurosurgery, Kimura Hospital, Tokyo, Japan

    Toshihiko Kubota

Authors
  1. Hiroaki Takeuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tetsuya Hosoda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ryuhei Kitai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Toshiaki Kodera
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hidetaka Arishima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Kenzo Tsunetoshi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Hiroyuki Neishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Takahiro Yamauchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Kazufumi Sato
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Yoshiyuki Imamura
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Hiroshi Itoh
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Toshihiko Kubota
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Ken-ichiro Kikuta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hiroaki Takeuchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Takeuchi, H., Hosoda, T., Kitai, R. et al. Clinicopathological features in the recurrence of oligodendroglioma and diffuse astrocytoma. Brain Tumor Pathol 29, 140–147 (2012). https://doi.org/10.1007/s10014-012-0104-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10014-012-0104-2

Keywords

Search

Navigation